Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
3.042
-0.018 (-0.59%)
Dec 3, 2024, 2:05 PM EST - Market open
Synaptogenix Market Cap
Synaptogenix has a market cap or net worth of $4.12 million as of December 3, 2024. Its market cap has decreased by -14.09% in one year.
Market Cap
4.12M
Enterprise Value
-17.51M
1-Year Change
-14.09%
Ranking
Category
Stock Price
$3.04
Market Cap Chart
Since December 15, 2020, Synaptogenix's market cap has decreased from $5.28M to $4.12M, a decrease of -21.93%. That is a compound annual growth rate of -6.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 4.24M | -23.47% |
| Dec 29, 2023 | 5.54M | -34.23% |
| Dec 30, 2022 | 8.43M | -85.16% |
| Dec 31, 2021 | 56.80M | 652.77% |
| Dec 31, 2020 | 7.55M | 42.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galmed Pharmaceuticals | 4.43M |
| Aptevo Therapeutics | 4.39M |
| Hepion Pharmaceuticals | 4.38M |
| XORTX Therapeutics | 4.35M |
| Creative Medical Technology Holdings | 4.28M |
| iCoreConnect | 4.15M |
| Alaunos Therapeutics | 4.12M |
| Revelation Biosciences | 4.08M |